Sex Differences in Postoperative Sleep Quality and Inflammation

April 28, 2022 updated by: Yanchao Yang, Shengjing Hospital

Sex Differences in Postoperative Sleep Quality and Inflammation in Patients Undergoing Video-Assisted Thoracoscopic Surgery

Video-Assisted Thoracoscopic Surgery(VATS) is among the most common and disabling persistent pain and inflammation conditions, with increasing prevalence in the developed world, and affects women to a greater degree than men. And sleep disruption also remains a challenging problem in surgical settings. Postoperative sleep disturbances (POSD) are defined as changes in the sleep structure and quality of patients during the early stages after surgery, which are manifested as significantly shortened rapid eye movement (REM) sleep, prolonged awake time, and sleep fragmentation. Long-term POSD may increase the risk of postoperative delirium or cognitive dysfunction and delay recovery, thereby worsening the patient's physical condition. The aim of the study was to investigate the effect of sex differences on postoperative pain, inflammation and sleep quality among patients who have undergone video-assisted thoracoscopic surgery under general anesthesia.

Study Overview

Study Type

Observational

Enrollment (Actual)

213

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Liaoning
      • Shenyang, Liaoning, China, 110004
        • Shengjing Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients undergoing video-assisted thoracoscopic surgery under general anesthesia

Description

Inclusion Criteria:

  • 18-80 years old
  • ASA I-III
  • under general anesthesia

Exclusion Criteria:

  • patients with central nervous system and mental diseases;
  • patients with preoperative sleep disturbances;
  • patients with a history of sedative, analgesic, or antidepression drug use;
  • patients with sleep apnea or moderate and severe obstructive sleep apnea-hypopnea syndrome;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Male Group
patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia
Female Group
patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sleep quality of one night before surgery
Time Frame: first night before surgery
Use Athens insomnia scale to test the sleep quality the first night before surgery
first night before surgery
sleep quality of first night after surgery
Time Frame: first night after surgery
Use Athens insomnia scale to test the sleep quality the first night after surgery
first night after surgery
sleep quality of third night after surgery
Time Frame: third night after surgery
Use Athens insomnia scale to test the sleep quality the third night after surgery
third night after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visual analog scale(VAS) score after surgery
Time Frame: one day before surgery
evaluate VAS score after surgery
one day before surgery
visual analog scale(VAS) score after surgery
Time Frame: 3 hours after surgery
evaluate VAS score after surgery
3 hours after surgery
visual analog scale(VAS) score after surgery
Time Frame: 8 pm the first day after surgery
evaluate VAS score after surgery
8 pm the first day after surgery
postoperative adverse effect
Time Frame: 24 hours after surgery
evaluate postoperative adverse effect 24 hours after surgery
24 hours after surgery
perioperative inflammation function
Time Frame: two days before surgery
evaluate neutrophils
two days before surgery
perioperative inflammation function
Time Frame: two days before surgery
evaluate platelet
two days before surgery
perioperative inflammation function
Time Frame: two days before surgery
evaluate lymphocyte
two days before surgery
perioperative inflammation function
Time Frame: first days after surgery
evaluate neutrophils,platelet,lymphocyte
first days after surgery
perioperative inflammation function
Time Frame: first days after surgery
evaluate neutrophils
first days after surgery
perioperative inflammation function
Time Frame: first days after surgery
evaluate platelet
first days after surgery
perioperative inflammation function
Time Frame: first days after surgery
evaluate lymphocyte
first days after surgery
Postoperative cognition evaluation
Time Frame: one day before surgery
Use MMSE Mini-Mental State Examination (MMSE) was also evaluated at Sleep preop 1, Sleep POD 1 and Sleep POD 3.18 Each correct answer is 1 point, and error or unknown is 0 point. The unsuitable one is 9 points, and refusing to answer or incomprehension is 8 points. In the total score, 8 points and 9 points are calculated by 0 points. The highest score is 30 points. The division of dementia or not is related to the degree of education. The dementia is affirmed by the patient who is illiterate and less than 17 points, the primary school is less than 20 points, and more than middle school is less than 24 points. The scores which from 27 to 30 is normal, 21 to 26 of mild, 10 to 20 of moderate, and from 0 to 9 is severe.
one day before surgery
Postoperative cognition evaluation
Time Frame: first day after surgery
Use MMSE Mini-Mental State Examination (MMSE) was also evaluated at Sleep preop 1, Sleep POD 1 and Sleep POD 3.18 Each correct answer is 1 point, and error or unknown is 0 point. The unsuitable one is 9 points, and refusing to answer or incomprehension is 8 points. In the total score, 8 points and 9 points are calculated by 0 points. The highest score is 30 points. The division of dementia or not is related to the degree of education. The dementia is affirmed by the patient who is illiterate and less than 17 points, the primary school is less than 20 points, and more than middle school is less than 24 points. The scores which from 27 to 30 is normal, 21 to 26 of mild, 10 to 20 of moderate, and from 0 to 9 is severe.
first day after surgery
Postoperative cognition evaluation
Time Frame: third day after surgery
Use MMSE Mini-Mental State Examination (MMSE) was also evaluated at Sleep preop 1, Sleep POD 1 and Sleep POD 3.18 Each correct answer is 1 point, and error or unknown is 0 point. The unsuitable one is 9 points, and refusing to answer or incomprehension is 8 points. In the total score, 8 points and 9 points are calculated by 0 points. The highest score is 30 points. The division of dementia or not is related to the degree of education. The dementia is affirmed by the patient who is illiterate and less than 17 points, the primary school is less than 20 points, and more than middle school is less than 24 points. The scores which from 27 to 30 is normal, 21 to 26 of mild, 10 to 20 of moderate, and from 0 to 9 is severe.
third day after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 31, 2020

Primary Completion (Actual)

February 20, 2022

Study Completion (Actual)

February 27, 2022

Study Registration Dates

First Submitted

October 23, 2020

First Submitted That Met QC Criteria

October 23, 2020

First Posted (Actual)

October 29, 2020

Study Record Updates

Last Update Posted (Actual)

May 4, 2022

Last Update Submitted That Met QC Criteria

April 28, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Video-Assisted Thoracoscopic Surgery

3
Subscribe